LONDON (Alliance News) - UDG Healthcare PLC on Thursday confirmed its earnings guidance for the full year as it said trading in the nine months to the end of June had been robust, with solid revenue and profit growth in its Sharp and Ashfield divisions.
The FTSE 250-listed healthcare services company said its revenue and adjusted operating profit for the nine months to the end of June is significantly ahead year-on-year, with good trading in its operating divisions and a further boost from favourable currency movements.
UDG said trading in its Ashfield Commercial & Medical Services business continues to be strong, with operating profit well ahead year-on-year in the third quarter. Sharp Packaging Services also delivered robust trading in the third quarter, with increased demand for bottling, biotech and new packaging formats. Its United Drug supply chain services arm traded in line with expectations in the quarter.
Shares in UDG were up 0.4% to 518.00 pence on Thursday morning.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
